Community Future of MedTech

$22 Million For Early Stage Research

The Australian Government has just announced $22 million over four years to support early-stage research into developing new and innovative cures and treatments for major diseases.

The Biomedical Translation Bridge grants will support successful applicants to fund and grow health and medical research projects from early stage to proof-of-concept and commercialisation.

The fund will be operated by MTPConnect through partnerships with BioCurate (University of Melbourne and Monash University) and UniQuest (University of Queensland), bringing together a wealth of experience in commercialisation of health and medical research in Australia.

The grants aim to bridge the barrier between new ideas and funding and commercialisation, to ensure that cutting edge new medical technology is available sooner to those who need it most.

Successful applicants will receive between $200,000 and $1 million over a maximum of three years.

For more information on the Biomedical Translation Bridge, visit:

Leave a Comment

Your email address will not be published.

You may also like

Newsletter Signup